ImmuDyne, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 8/18/2017
Contact Info
  • 1460 Broadway
  • New York, NY 10036

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0000948320
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Mark McLaughlin President, CEO
Robert Kalkstein CFO
Anthony Bruzzese, M.D. Outside Director
Ryan Aldridge Outside Director
Joseph DiTrolio Outside Director
Company Directors
John Strawn Chairman, Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Dr. Michael Borenstein
Stefan Galluppi
Justin Schreiber
Service Providers
Accounting/Auditing Firm
PKF O'Connor Davies, LLP
29 Broadway
New York, NY, 10006
United States
Securities Counsel Investor Relations Firm

Not Available
Company History
  • Formerly=Anina Resources, Inc to 11-87
IMMD Security Details
Share Structure
Market Value1 $14,578,682 a/o Jan 12, 2018
Authorized Shares 50,000,000 a/o Sep 30, 2016
Outstanding Shares 44,393,063 a/o Nov 14, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 13,990,119 a/o Aug 15, 2016
Par Value 0.01
Transfer Agent(s)
Shareholders of Record 324 a/o May 24, 2017
Short Selling Data
Short Interest 14,244 (-75.6%)
Dec 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security